Votes: NJ A2022 | 2020-2021 | Regular Session

Bill Title: Prohibits pre-approval or precertification of cancer treatments, tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.

Spectrum: Slight Partisan Bill (Democrat 5-3)

Status: (Introduced - Dead) 2020-01-14 - Introduced, Referred to Assembly Health Committee [A2022 Detail]

Text: Latest bill text (Introduced) [HTML]

Voting Records

ChamberVoteDateYeaNayNVAbsTotalResultSourceView
No roll call record information currently on file.
States not producing parsable votes may be available as images in Supplemental Documents.

Social Comments on NJ A2022

feedback